Brief: Fulgent Genetics And Helio Health Announce Strategic Partnership To Commercialize Early Cancer Detection Tests
09/08/2021 21:04
Aug 9 (Reuters) - Fulgent Genetics Inc FLGT.O :
* FULGENT GENETICS AND HELIO HEALTH ANNOUNCE STRATEGIC
PARTNERSHIP
TO COMMERCIALIZE EARLY CANCER DETECTION TESTS
* FULGENT GENETICS INC - COMPANIES WILL INITIALLY
COMMERCIALIZE
AND CO-BRAND HELIOLIVER
Source text for Eikon: ID:nBwbbStvPa
Further company coverage: FLGT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fulgent Genetics
See all newsU.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
Fulgent Genetics Inc reports results for the quarter ended June 30 - Earnings Summary
Fulgent Genetics Q2 revenue rises 20% sequentially, sees billing system transition delay
Brief: Fulgent Genetics Q2 Revenue USD 85.389 Million
Fulgent Genetics Inc expected to post a loss of 46 cents a share - Earnings Preview